Literature DB >> 7520285

Recombinant methionyl granulocyte colony-stimulating factor (filgrastim): a new dimension in immunotherapy.

G Schwab, T Hecht.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7520285     DOI： 10.1007/bf01757341

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  84 in total

Review 1.  Hemopoietic cell growth factors and their receptors.

Authors:  N A Nicola
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

2.  Binding characteristics and proliferative action of purified granulocyte colony-stimulating factor (G-CSF) on normal and leukemic human promyelocytes.

Authors:  C G Begley; D Metcalf; N A Nicola
Journal:  Exp Hematol       Date:  1988-01       Impact factor: 3.084

3.  Why do hemopoietic growth factor receptors interact with each other?

Authors:  N A Nicola
Journal:  Immunol Today       Date:  1987

Review 4.  Clinical use of recombinant human hematopoietic growth factors.

Authors:  J Laver; M A Moore
Journal:  J Natl Cancer Inst       Date:  1989-09-20       Impact factor: 13.506

5.  Response of leukemic cells to the sequential combination of GM-CSF and G-CSF.

Authors:  C Inoue; T Murate; T Hotta; H Saito
Journal:  Int J Cell Cloning       Date:  1990-01

6.  Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease.

Authors:  K M Taylor; S Jagannath; G Spitzer; J A Spinolo; S L Tucker; B Fogel; F F Cabanillas; F B Hagemeister; L M Souza
Journal:  J Clin Oncol       Date:  1989-12       Impact factor: 44.544

7.  Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy.

Authors:  A Lindemann; F Herrmann; W Oster; G Haffner; W Meyenburg; L M Souza; R Mertelsmann
Journal:  Blood       Date:  1989-12       Impact factor: 22.113

Review 8.  Dose-response in the treatment of breast cancer: a critical review.

Authors:  I C Henderson; D F Hayes; R Gelman
Journal:  J Clin Oncol       Date:  1988-09       Impact factor: 44.544

9.  Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF.

Authors:  S Hohaus; H Goldschmidt; R Ehrhardt; R Haas
Journal:  Exp Hematol       Date:  1993-04       Impact factor: 3.084

10.  Pharmacokinetics of subcutaneous recombinant human granulocyte colony-stimulating factor in children.

Authors:  N Stute; V M Santana; J H Rodman; M J Schell; J N Ihle; W E Evans
Journal:  Blood       Date:  1992-06-01       Impact factor: 22.113
View more
  1 in total

1.  Granulocyte colony-stimulating factor (G-CSF) serum levels in surgical intensive care patients.

Authors:  W Gross-Weege; K Dumon; A Dahmen; E M Schneider; H D Röher
Journal:  Infection       Date:  1997 Jul-Aug       Impact factor: 3.553
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.